Abstract Background N6-methyladenosine (m6A) is the most prevalent RNA epigenetic
regulation in eukaryotic cells. However, understanding of m6A in colorectal cancer (CRC) is …

Epigenetic alterations contributed to human carcinogenesis immensely. N6-
methyladenosine (m6A) is one of the most preventive and abundant modifications on RNA …

Background Colorectal carcinoma (CRC) is one of the most common malignant tumors, and
its main cause of death is tumor metastasis. RNA N 6-methyladenosine (m 6 A) is an …

Background & Aims RNA N 6-methyladenosine (m 6 A) modification has recently emerged
as a new regulatory mechanism in cancer progression. We aimed to explore the role of the …

Purpose Although many biological processes are involved in the modification of N6-
methyladenosine (m6A), the exact role of m6A in the development of malignant tumors …

Abstract N6-methyladenosine (m6A) modification is the most common chemical modification
in eukaryotic mRNA, which plays a crucial role in regulating mRNA stability, splicing, and …

Background Colorectal carcinoma (CRC) is the third most common cancer and second most
common cause of cancer-related deaths worldwide. Ribonucleic acid (RNA) N6 …

Background Colorectal cancer (CRC) is one of the leading causes of tumor-related death
worldwide, and its main cause of death is distant metastasis. Methyltransferase-like 14 …

Colorectal cancer (CRC), including colon adenocarcinoma (COAD) and rectal
adenocarcinoma (READ), is one of the most prevalent malignancies worldwide. N 6 …

Background & Aims N 6-Methyladenosine (m 6 A) is the most prevalent RNA modification
and recognized as an important epitranscriptomic mechanism in colorectal cancer (CRC) …